Real-World Evaluation of the Effect of Jublia on Nail Polish
NCT03022916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2020-01-06
Summary
A recent publication using cadaver nails suggests that Jublia application has a negative effect on nail polish texture.
Conditions
- Evaluation of Jublia on Nail Polish With Healthy Toenails
Interventions
- DRUG
-
Nail Polish + Efinaconazole Solution
Application of Jublia to the nail of one big toe on top of the nail polish
- OTHER
-
Nail polish
Application of nail polish only to both big toe nails
- DRUG
-
Base Coat + Nail Polish + Top Coat + Efinaconazole Solution
Application of Jublia to the nail of one big toe on top of the nail polish with layers of top coat and base coat
- DRUG
-
Nail Polish + Top Coat + Efinaconazole Solution
Application of Jublia to the nail of one big toe on top of the nail polish with layer of top coat
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2017-09-30
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
NCT03578029 ·Status: TERMINATED ·Phase: PHASE2
-
Topical Cyclosporine and Disease Progression
NCT00567983 ·Status: COMPLETED ·Phase: PHASE4
-
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
NCT02834520 ·Status: COMPLETED
-
Effects of Topical SLPI on Skin Wounds
NCT00005569 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
NCT06917690 ·Status: RECRUITING ·Phase: PHASE3
-
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
NCT03816189 ·Status: COMPLETED
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
NCT02166229 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
NCT03398837 ·Status: TERMINATED ·Phase: PHASE3
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Oral Health and People With Systemic Sclerosis
NCT01817361 ·Status: COMPLETED
-
Simvastatin Treatment of Pachyonychia Congenita
NCT01382511 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Divozilimab in Patients With Systemic Scleroderma
NCT05726630 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
NCT00697034 ·Status: TERMINATED ·Phase: PHASE4
-
Calcinosis Reduction by Pyrophosphate in SSC
NCT04966416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
NCT06857240 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
NCT00668473 ·Status: COMPLETED
-
Oral Type I Collagen for Relieving Scleroderma
NCT00005675 ·Status: COMPLETED ·Phase: PHASE2
-
Neurobiology of the Scalp in Seborrheic Dermatitis
NCT02349854 ·Status: COMPLETED
-
Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.
NCT05288478 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
NCT02921971 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED
-
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
NCT02152007 ·Status: COMPLETED ·Phase: PHASE1